iCAD, Inc. (ICAD) Announces Poster Presentation of Xoft System to Treat Skin Cancer Highlighted at 2013 American Brachytherapy Society Annual Meeting
4/22/2013 6:42:08 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that positive data in support of the Company’s Xoft® Axxent® Electronic Brachytherapy System® to treat non-melanoma skin cancer (NMSC) were highlighted in a poster presentation today at the 2013 American Brachytherapy Society (ABS) Annual Meeting being held from April 18-20, 2013 in New Orleans.
Help employers find you! Check out all the jobs and post your resume.
comments powered by